David Pernock
2016 - Fibrocell Science
In 2016, David Pernock earned a total compensation of $1.3M as Former Chairman of the Board and Chief Executive Officer at Fibrocell Science, a 3% increase compared to previous year.
Compensation breakdown
| Option Awards | $741,327 |
|---|---|
| Salary | $471,154 |
| Other | $47,115 |
| Total | $1,259,596 |
Pernock received $741.3K in option awards, accounting for 59% of the total pay in 2016.
Pernock also received $471.2K in salary and $47.1K in other compensation.
Rankings
In 2016, David Pernock's compensation ranked 7,137th out of 14,075 executives tracked by ExecPay. In other words, Pernock earned more than 49.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,137 out of 14,075 | 49th |
Division Manufacturing | 2,687 out of 5,486 | 51st |
Major group Chemicals And Allied Products | 879 out of 1,900 | 54th |
Industry group Drugs | 679 out of 1,543 | 56th |
Industry Pharmaceutical Preparations | 538 out of 1,173 | 54th |
Source: SEC filing on April 27, 2017.
Pernock's colleagues
We found three more compensation records of executives who worked with David Pernock at Fibrocell Science in 2016.
News
Eagle Pharmaceuticals CEO Scott Tarriff's 2021 pay falls 32% to $6.5M
June 15, 2022
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M
April 30, 2021
Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
April 29, 2020
Eagle Pharmaceuticals CEO Scott Tarriff's 2018 pay jumps 41% to $11M
April 30, 2019